Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliografische gegevens
Hoofdauteur:	Akter, Honufa
Andere auteurs:	Sharmin, Sabrina
Formaat:	Thesis
Taal:	English
Gepubliceerd in:	Brac University 2024
Onderwerpen:	Doxorubicin Breast cancer Liposome Liposomal doxorubicin Cardiotoxicity Metastasis Breast cancer > Treatment.
Online toegang:	http://hdl.handle.net/10361/23619

Gelijkaardige items

Breast cancer therapy through Liposomal drug delivery system
door: Ome, Nusrat Jahan
Gepubliceerd in: (2024)

Potential of liposomes for the treatment of lung cancer- a review
door: Mim, Shanzida
Gepubliceerd in: (2023)

Recent advancement on breast cancer detection and treatment
door: Rahman, Sanjida
Gepubliceerd in: (2023)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
door: Raihan, Dilraj
Gepubliceerd in: (2024)

Natural products and their combinatory effects in breast cancer treatment
door: Siddique, Md. Ayman
Gepubliceerd in: (2021)

Targeted therapeutic options in the treatment of Breast Cancer
door: Alam, Kazi Tasnuva
Gepubliceerd in: (2022)

Breast cancer awareness seminars
door: Anwer Khan Modern Medical College
Gepubliceerd in: (2016)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
door: Nahar, Kamrun
Gepubliceerd in: (2023)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
door: Chakraborty, Anuradha
Gepubliceerd in: (2024)

A review on triple-negative breast cancer and its potential treatment
door: Niasa, Jannatul Ferdous
Gepubliceerd in: (2023)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
door: Shobnam, Sohana
Gepubliceerd in: (2024)

The impact of breast cancer on women’s lives in Bangladesh
door: Mobashera, Tayeeba Tum
Gepubliceerd in: (2024)

Machine learning as an indicator for breast cancer prediction
door: Shadman, Tahsin Mohammed, et al.
Gepubliceerd in: (2019)

Breast cancer in low-resource settings: Prioritizing the awareness and access programmes to overcome sociocultural and economic barriers for early detection and improved outcomes
door: Iqbal, Mohammad Shamim, et al.
Gepubliceerd in: (2017)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
door: Araf, Faiaz Fahim
Gepubliceerd in: (2024)

Pathway analysis of Disease-Gene associated network in the human breast cancer
door: Lamia
Gepubliceerd in: (2020)

Anthracycline induced cardiotoxicity: A systematic review
door: Azam, Faruque
Gepubliceerd in: (2018)

Breast cancer in South Asia: a Bangladeshi perspective
door: Hossain, Mohammad Sorowar, et al.
Gepubliceerd in: (2017)

Early detection of breast cancer using machine learning
door: Fuad, Wasi Mohammad
Gepubliceerd in: (2019)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
door: Nuha, Nabiha Tahsin
Gepubliceerd in: (2024)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
door: Oishy, Jannatun Noor
Gepubliceerd in: (2024)

Breast cancer prediction using different machine learning models
door: Khandker Al- Muhaimin, et al.
Gepubliceerd in: (2020)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
door: Mirza, Maisa Tasnim
Gepubliceerd in: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
door: Hasan, Sakib
Gepubliceerd in: (2024)

Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population
door: Parvin, Salma, et al.
Gepubliceerd in: (2016)

Oncogenes: new targets in cancer treatment
door: Chowdhury, Waseka Shams
Gepubliceerd in: (2020)

Current practice and approaches of immunotherapy in Cancer treatment
door: Khondokar, Faiza
Gepubliceerd in: (2022)

Machine learning In breast cancer prognosis and prediction
door: Chowdhury, Shah Abul Hasnat, et al.
Gepubliceerd in: (2023)

RIPK pathway, as a potential target, for cancer treatment - a review
door: Jahan, Nusrat
Gepubliceerd in: (2024)

Biosimilar in lymphoma treatment
door: Tanisha, Mehrin Haque
Gepubliceerd in: (2021)

A comprehensive review on drug repurposing in cancer treatment
door: Sarkar, Onusree
Gepubliceerd in: (2024)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
door: Muntaha, Habibatul
Gepubliceerd in: (2023)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
door: Rahman, Qazi Ashrafur
Gepubliceerd in: (2018)

Targeting BRAFV600E in the treatment of CRC
door: Roja, Mashwiyat Samrin
Gepubliceerd in: (2024)

A review on recent advances in drugs for lung cancer treatment
door: Noor, Fouzia
Gepubliceerd in: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
door: Rahman, Tasnim
Gepubliceerd in: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
door: Abir, Shifaty Nur
Gepubliceerd in: (2024)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
door: Alam, Tahera
Gepubliceerd in: (2024)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
door: Hossain, Safa Binte
Gepubliceerd in: (2019)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
door: Karim, Azrin
Gepubliceerd in: (2024)